Fidelity Investments’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.25M Sell
3,744,427
-2,808
-0.1% -$6.94K ﹤0.01% 1962
2025
Q1
$7.46M Sell
3,747,235
-54,793
-1% -$109K ﹤0.01% 2016
2024
Q4
$11.1M Buy
3,802,028
+58,716
+2% +$171K ﹤0.01% 1905
2024
Q3
$14.5M Sell
3,743,312
-184,541
-5% -$714K ﹤0.01% 1813
2024
Q2
$20.2M Buy
3,927,853
+3,483
+0.1% +$17.9K ﹤0.01% 1648
2024
Q1
$27.5M Sell
3,924,370
-976
-0% -$6.83K ﹤0.01% 1546
2023
Q4
$34.8M Buy
3,925,346
+2,930
+0.1% +$26K ﹤0.01% 1430
2023
Q3
$37.4M Sell
3,922,416
-116,803
-3% -$1.11M ﹤0.01% 1352
2023
Q2
$59.2M Sell
4,039,219
-4,477,910
-53% -$65.6M 0.01% 1212
2023
Q1
$105M Buy
8,517,129
+54,083
+0.6% +$665K 0.01% 967
2022
Q4
$157M Buy
+8,463,046
New +$157M 0.02% 785